ConCallIQ
Go Pro

Coforge FY26 Annual Earnings Summary

4 quarters covered · ₹16,357 Cr revenue · ₹1,744 Cr PAT · 8.9% average EBITDA margin.

Total annual revenue: ₹16,357 Cr
Annual PAT: ₹1,744 Cr
Average margin: 8.9%
Promise delivery: 0%

Quarter-by-quarter progression

QuarterRevenuePATMarginSentiment
Q1 FY26₹3,689 Cr₹356 Crbullish
Q2 FY26₹3,986 Cr₹425 Crbullish
Q3 FY26₹4,232 Cr₹297 Cr17.0%bullish
Q4 FY26₹4,450 Cr₹666 Cr18.6%bullish

Management promises made during the year

Very strong growth in FY26

Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.

Q1 FY26
missed
Reported EBIT to expand materially in FY26

Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.

Q1 FY26
missed
Free cash flow to PAT ratio of 70-80%

Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.

Q3 FY26
missed
14% EBIT margin for FY26

Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.

Q4 FY26
missed

Risks flagged during the year

Q1 FY26 · medium

Tariff uncertainties and macro volatility continue to cause oscillation in run-the-enterprise budgets, potentially affecting discretionary spending.

Q1 FY26 · medium

Ramp-up of the largest deal and increased visa costs, subcontractor expenses, and depreciation weighed on margins in Q1; wage hike in Q3 could pose further headwinds.

Q2 FY26 · medium

Annual wage hike effective October 1, 2025, expected to cause a 100-150 bps margin drop in Q3, partially offset by other levers.

Q2 FY26 · medium

EMEA has seen delays and slowdowns in deal sign-offs, though management expects recovery in the next two quarters.

Q3 FY26 · medium

Integration of Encora may face challenges in achieving synergies and margin targets, with integration expenses expected in Q4 and Q1.

Q3 FY26 · medium

Hedge losses of INR 434 million in Q3 adversely impacted reported EBIT by 26bps; management is revisiting hedging strategy but no final decision yet.

Q4 FY26 · medium

BFS revenue grew only 12% in FY26, stuck at ~$120-123M for five quarters due to a large client account issue. Recovery depends on management's refactoring efforts.

Q4 FY26 · medium

Industry-wide AI-driven code generation could compress billing rates, though management argues total cost of ownership remains high and managed services will offset.

Q1 FY26 · low

The merger closure depends on regulatory approvals, which could slip beyond the December-January timeline.

Q1 FY26 · low

Higher CapEx for the AI data center deal impacted free cash flow; while management expects normalization, sustained asset-heavy deals could strain cash generation.

Q2 FY26 · low

Management expects furloughs at the same scale as previous years, which could affect Q4 revenue sequentially.

Q2 FY26 · low

Hedge losses doubled to INR 307 million in Q2, creating a 150 bps gap between constant currency and dollar revenue growth.

What changed through the year

G

Q1 FY26 · 14% EBIT margin target for FY26

Management reiterated a pathway to 14% reported EBIT margin for the full fiscal year, supported by operational leverage and cost optimization.

G

Q1 FY26 · At least 20 large deals in FY26

The company aims to close at least 20 large deals in the current fiscal year, up from 14 in the prior year.

G

Q1 FY26 · H2 growth stronger than H1

Management expects second half revenue growth to be much stronger than first half due to large deal ramp-ups.

G

Q1 FY26 · Signiti merger closure by Dec 2025/Jan 2026

The merger with Signiti is expected to close by December 2025 or January 2026, with effective date of April 1, 2025.

G

Q2 FY26 · 14% EBIT margin target for FY26

Management targets a reported EBIT margin of 14% for the full fiscal year, with Q4 expected to achieve this level despite wage hike headwinds in Q3.

G

Q2 FY26 · H2 FY26 growth to be robust

Management expects H2 to be a growth half over H1, with Q4 traditionally the strongest quarter, supported by pipeline and deal momentum.

G

Q2 FY26 · Free cash flow to PAT ratio of 70-80%

On a sustained basis, free cash flow to PAT is expected to be around 70-80%, with focus on maintaining this metric.

G

Q2 FY26 · Healthcare vertical to approach $100M run rate

Healthcare book of business expected to be near $100 million by end of FY26, with potential separate reporting from Q1 FY27.

G

Q3 FY26 · 14% EBIT margin for FY26

Management reiterated guidance of 14% EBIT margin for full fiscal year 2026, with Q4 expected to deliver 15% EBIT.

G

Q3 FY26 · Exceptional FY27 growth

Management expects FY27 to be an exceptional year, with continued robust growth driven by large deal pipeline and key account momentum.

G

Q3 FY26 · No EPS dilution from Encora in FY27

Management confirmed that the guidance of no EPS dilution in FY27 for the combined business remains intact, even after finalizing a term loan instead of QIP.

G

Q4 FY26 · FY27 Consolidated EBITDA Margin 20.5-21%

Management guided EBITDA margins of 20.5% to 21% for FY27 on a consolidated basis, driven by AI automation, G&A leverage, and Enkora synergies.

G

Q4 FY26 · FY27 Standalone EBIT Margin 16.5-17%

Standalone EBIT margin expected between 16.5% and 17% in FY27, excluding Enkora amortization.

G

Q4 FY26 · FCF to PAT at 100%+ from FY27

Free cash flow to PAT ratio expected to be at least 100% from FY27 onwards, up from earlier guidance of 70-80%.

G

Q4 FY26 · Q1 FY27 Revenue Flattish QoQ Due to India Business Exit

Revenue in Q1 FY27 expected to be flattish sequentially due to discontinuation of ~$20M low-margin India business, with growth resuming from Q2.